Content related to Want to Know How New Cancer Treatments Affect Children? Ask Them

Sex-based differences in incidence and long-term outcomes have been well documented in pediatric cancer patients. Investigators at Children’s Hospital Los Angeles have now discovered similar

Researchers have been delving deeper to better understand long-term cancer survival and quality of life for adolescent and young adult patients.

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

Patients with acute lymphoblastic leukemia are at increased risk for bone fractures due to bone loss resulting from treatment. This decrease in bone density (as illustrated here) can occur as soon as

Investigators from Children’s Hospital Los Angeles and 37 other Children’s Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing

Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma